2016 review

Nanoparticles and direct immunosuppression

[Review of ]. EXPERIMENTAL BIOLOGY AND MEDICINE, 241(10), 1064–1073.

co-author countries: United States of America πŸ‡ΊπŸ‡Έ
author keywords: Nanoparticles; immunosuppression; bionanoscience; nanotoxicology; immunotoxicity; anti-inflammatory
MeSH headings : Animals; Drug Carriers / metabolism; Humans; Immunosuppression Therapy / methods; Immunosuppressive Agents / pharmacokinetics; Immunosuppressive Agents / pharmacology; Nanoparticles / metabolism
Source: Web Of Science
Added: August 6, 2018

Targeting the immune system with nanomaterials is an intensely active area of research. Specifically, the capability to induce immunosuppression is a promising complement for drug delivery and regenerative medicine therapies. Many novel strategies for immunosuppression rely on nanoparticles as delivery vehicles for small-molecule immunosuppressive compounds. As a consequence, efforts in understanding the mechanisms in which nanoparticles directly interact with the immune system have been overshadowed. The immunological activity of nanoparticles is dependent on the physiochemical properties of the nanoparticles and its subsequent cellular internalization. As the underlying factors for these reactions are elucidated, more nanoparticles may be engineered and evaluated for inducing immunosuppression and complementing immunosuppressive drugs. This review will briefly summarize the state-of-the-art and developments in understanding how nanoparticles induce immunosuppressive responses, compare the inherent properties of nanomaterials which induce these immunological reactions, and comment on the potential for using nanomaterials to modulate and control the immune system.